Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Noorwati Sutandyo, Arif Riswahyudi Hanafi, Achmad Mulawarman Jayusman, Sri Agustini Kurniawati & Muhamad Alfin Hanif. (2023) Overweight and Obesity are Associated with Poorer Survival Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemotherapy. International Journal of General Medicine 16, pages 85-93.
Read now
Read now
Gerhard Hamilton & Barbara Rath. (2018) Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1. Expert Opinion on Drug Metabolism & Toxicology 14:1, pages 17-24.
Read now
Read now
Augusto Nogueira, Joana Assis, Ilda Faustino, Deolinda Pereira, Raquel Catarino & Rui Medeiros. (2017) Base excision repair pathway: PARP1 genotypes as modulators of therapy response in cervical cancer patients. Biomarkers 22:1, pages 70-76.
Read now
Read now
Mariacarmela Santarpia, Christian Rolfo, G. J. Peters, Leticia G. Leon & Elisa Giovannetti. (2016) On the pharmacogenetics of non-small cell lung cancer treatment. Expert Opinion on Drug Metabolism & Toxicology 12:3, pages 307-317.
Read now
Read now
Ahmed El Sayed Mohammed, Hidetaka Eguchi, Satoru Wada, Nobuyuki Koyama, Michio Shimizu, Keiko Otani, Megu Ohtaki, Keiji Tanimoto, Keiko Hiyama, Mohammed Soliman Gaber & Masahiko Nishiyama. (2012)
TMEM158 and FBLP1 as novel marker genes of cisplatin sensitivity in non-small cell lung cancer cells. Experimental Lung Research 38:9-10, pages 463-474.
Read now
Read now
Articles from other publishers (50)
Qiang Liu, Qiu Peng, Bin Zhang & Yueqiu Tan. (2023) X-ray cross-complementing family: the bridge linking DNA damage repair and cancer. Journal of Translational Medicine 21:1.
Crossref
Crossref
Jéssika Cristina Chagas Lesbon, Taismara Kustro Garnica, Pedro Luiz Porfírio Xavier, Arina Lázaro Rochetti, Rui Manuel Reis, Susanne Müller & Heidge Fukumasu. (2022) A Screening of Epigenetic Therapeutic Targets for Non-Small Cell Lung Cancer Reveals PADI4 and KDM6B as Promising Candidates. International Journal of Molecular Sciences 23:19, pages 11911.
Crossref
Crossref
Shih-Hui Huang, Chao-Yu Chu, Yu-Chia Hsu, San-Yuan Wang, Li-Na Kuo, Kuan-Jen Bai, Ming-Chih Yu, Jer-Hwa Chang, Eugene H. Liu & Hsiang-Yin Chen. (2022) How platinum-induced nephrotoxicity occurs? Machine learning prediction in non-small cell lung cancer patients. Computer Methods and Programs in Biomedicine 221, pages 106839.
Crossref
Crossref
Kangwook Lee, Bo-Young Youn, Yu-Jeong Choi, Seunghwan Moon, Jungkwun Im, Kyongha Cho, Seong-Gyu Ko & Chunhoo Cheon. (2022) State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent. Cancers 14:4, pages 1089.
Crossref
Crossref
Munindra Ruwali, Keshav Moharir, Sanjiv Singh, Punita Aggarwal & Manash K. Paul. 2021. Pharmacogenetics. Pharmacogenetics.
Mi-So Jeong, Kang-Wook Lee, Yu-Jeong Choi, Yun-Gyeong Kim, Hyun-Ha Hwang, Seo-Yeon Lee, Se-Eun Jung, Sun-Ah Park, Jin-Hee Lee, Yong-Joon Joo, Sung-Gook Cho & Seong-Gyu Ko. (2021) Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences 22:16, pages 8405.
Crossref
Crossref
Rachel M Hurley, Cordelia D McGehee, Ksenija Nesic, Cristina Correia, Taylor M Weiskittel, Rebecca L Kelly, Annapoorna Venkatachalam, Xiaonan Hou, Nicholas M Pathoulas, X Wei Meng, Olga Kondrashova, Marc R Radke, Paula A Schneider, Karen S Flatten, Kevin L Peterson, Marc A Becker, Ee Ming Wong, Melissa S Southey, Alexander Dobrovic, Kevin K Lin, Thomas C Harding, Iain McNeish, Christian A Ross, Jill M Wagner, Matthew J Wakefield, Clare L Scott, Paul Haluska, Andrea E Wahner Hendrickson, Larry M Karnitz, Elizabeth M Swisher, Hu Li, S John Weroha & Scott H Kaufmann. (2021)
Characterization of a
RAD51C
-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance
. NAR Cancer 3:3.
Crossref
Crossref
Vignesh Kumar, Sairam Yadavilli & Raghuraman Kannan. (2020)
A review on
RNAi
therapy for
NSCLC
: Opportunities and challenges
. WIREs Nanomedicine and Nanobiotechnology 13:2.
Crossref
Crossref
Jelena Spasić, Davorin Radosavljević & Ljudmila Nagorni-Obradović. (2021) The influence of genetic polymorphisms on the toxicity of platinum-based chemotherapy in the treatment of non-small cell lung cancer. Medicinski podmladak 72:2, pages 40-47.
Crossref
Crossref
Zhaolong Zeng, Guofang Zhao, Huangkai Zhu, Liangqin Nie, Lifeng He, Jiangtao Liu, Rui Li, Shuai Xiao & Gang Hua. (2020) LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis. Cancer Cell International 20:1.
Crossref
Crossref
Chunjie Zhang, Shan Gao & Jingwen Hou. (2020) ERCC1 expression and platinum chemosensitivity in patients with ovarian cancer: A meta-analysis. The International Journal of Biological Markers 35:4, pages 12-19.
Crossref
Crossref
Yi Zheng, Zheng Deng, Mimi Tang, Di Xiao & Pei Cai. (2020) Impact of genetic factors on platinum-induced gastrointestinal toxicity. Mutation Research/Reviews in Mutation Research 786, pages 108324.
Crossref
Crossref
YingQing Zhang, Yan Feng, YongLei Wu, YingXin Zhou & LinLan Wang. (2020) Comparative clinical study on microwave ablation combined with gemcitabine and cisplatin or combined with pemetrexed and cisplatin in treatment of advanced NSCLC. The Clinical Respiratory Journal 14:9, pages 864-870.
Crossref
Crossref
Iris Z. Uras, Herwig P. Moll & Emilio Casanova. (2020) Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future. International Journal of Molecular Sciences 21:12, pages 4325.
Crossref
Crossref
Aina Calls, Valentina Carozzi, Xavier Navarro, Laura Monza & Jordi Bruna. (2020) Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies. Experimental Neurology 325, pages 113141.
Crossref
Crossref
Hongge Zhu, Jie Yang & Shun'e Yang. (2020) MicroRNA‑103a‑3p potentiates chemoresistance to cisplatin in non‑small cell lung carcinoma by targeting neurofibromatosis 1. Experimental and Therapeutic Medicine.
Crossref
Crossref
Feng Xu, Jian Yang, Beizheng Xu, Zhenzhen Li, Xuanmei Li, Xiaotang Wu & Haiyan Liu. (2020) RETRACTED: Clinical Research on Systemic Chemotherapy Combined With Bronchoscopic Seed Implantation in the Treatment of Advanced Lung Cancer. Technology in Cancer Research & Treatment 19, pages 153303382097160.
Crossref
Crossref
Yadong Wang, Shaorui Liu, Wei Dong, Xiao Qu, Cuicui Huang, Tao Yan & Jiajun Du. (2019) Combination of hesperetin and platinum enhances anticancer effect on lung adenocarcinoma. Biomedicine & Pharmacotherapy 113, pages 108779.
Crossref
Crossref
Mao Dong Zheng, Nai Dong Wang, Xiao Liang Li, Juan Yan, Jian Hua Tang, Xiu Hua Zhao & Zhihua Zhang. (2018) Toosendanin mediates cisplatin sensitization through targeting Annexin A4/ATP7A in non-small cell lung cancer cells. Journal of Natural Medicines 72:3, pages 724-733.
Crossref
Crossref
Iván Galván-Femenía, Marta Guindo, Xavier Duran, Sílvia Calabuig-Fariñas, Josep Maria Mercader, Jose Luis Ramirez, Rafael Rosell, David Torrents, Anna Carreras, Takashi Kohno, Eloisa Jantus-Lewintre, Carlos Camps, Manuel Perucho, Lauro Sumoy, Jun Yokota & Rafael de Cid. (2018) Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2. Cancer Treatment and Research Communications 15, pages 21-31.
Crossref
Crossref
Yong Liu, Chunxi He & Xianping Huang. (2017) Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism. Oncotarget 8:43, pages 75206-75216.
Crossref
Crossref
Lin Yang, Shanshan Zou, Chang Shu, Yan Song, Yong-Kun Sun, Wen Zhang, Aiping Zhou, Xinghua Yuan, Yi Yang & Songnian Hu. (2017) CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients. Genomics, Proteomics & Bioinformatics 15:4, pages 255-262.
Crossref
Crossref
Yi Xiong, Bi-Yun Huang & Ji-Ye Yin. (2017) Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems. Medical Oncology 34:4.
Crossref
Crossref
Juan Chen, Zhan Wang, Ting Zou, Jiajia Cui, Jiye Yin, Wei Zheng, Wuzhong Jiang, Honghao Zhou & Zhaoqian Liu. (2016) Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysis. Oncotarget 7:34, pages 55741-55756.
Crossref
Crossref
Ji-Ye Yin, Xi Li, Xiang-Ping Li, Ling Xiao, Wei Zheng, Juan Chen, Chen-Xue Mao, Chao Fang, Jia-Jia Cui, Cheng-Xian Guo, Wei Zhang, Yang Gao, Chun-Fang Zhang, Zi-Hua Chen, Hui Zhou, Hong-Hao Zhou & Zhao-Qian Liu. (2016) Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients. Cancer Letters 377:1, pages 65-73.
Crossref
Crossref
TIAN YANG, MINGWEI CHEN, TIANJUN CHEN & ASMITANANDA THAKUR. (2015) Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer. Oncology Letters 10:4, pages 2584-2590.
Crossref
Crossref
HAIJIAO JIANG, HE WANG, SHIYU WANG, ZHENGTONG PEI, ZHIMIN FU, CHANGQING FANG, JIAN WANG, QINGJIE LU, ENHUA WANG & JIANHUA LI. (2015) Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy. Molecular Medicine Reports 11:5, pages 3523-3532.
Crossref
Crossref
Xiaohong Fan & Qingyu Xiu. (2015) Effect of X-ray repair cross complementing group 1 polymorphisms on the efficacy of platinum-based chemotherapy in patients with nonsmall cell lung cancer. Journal of Cancer Research and Therapeutics 11:3, pages 571-574.
Crossref
Crossref
Mircea Gabriel Stoleriu, Volker Steger, Migdat Mustafi, Martin Michaelis, Jindrich Cinatl, Wilke Schneider, Andrea Nolte, Julia Kurz, Hans Peter Wendel, Christian Schlensak & Tobias Walker. (2014) A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3†. European Journal of Cardio-Thoracic Surgery 46:5, pages 877-886.
Crossref
Crossref
Maimon C. Rose, Elina Kostyanovskaya & R. Stephanie Huang. (2014) Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer. Genomics, Proteomics & Bioinformatics 12:5, pages 198-209.
Crossref
Crossref
Ivana Sullivan, Juliana Salazar, Margarita Majem, Cinta Pallarés, Elisabeth del Río, David Páez, Montserrat Baiget & Agustí Barnadas. (2014) Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Letters 353:2, pages 160-166.
Crossref
Crossref
Z. Zhang, Y. Xu, N. Sun, M. Zhang, J. Xie & Z. Jiang. (2014) High Sam68 expression predicts poor prognosis in non-small cell lung cancer. Clinical and Translational Oncology 16:10, pages 886-891.
Crossref
Crossref
Gang Tian, Miaomiao Wang & Xiaogang Xu. (2014) The Role of NQO1 Polymorphisms in the Susceptibility and Chemotherapy Response of Chinese NSCLC Patients. Cell Biochemistry and Biophysics 69:3, pages 475-479.
Crossref
Crossref
Timothy G. Whitsett, Ian T. Mathews, Michael H. Cardone, Ryan J. Lena, William E. Pierceall, Michael Bittner, Chao Sima, Janine LoBello, Glen J. Weiss & Nhan L. Tran. (2014) Mcl-1 Mediates TWEAK/Fn14-Induced Non–Small Cell Lung Cancer Survival and Therapeutic Response. Molecular Cancer Research 12:4, pages 550-559.
Crossref
Crossref
Charlotta Ryk, Sai-Mei Hou, Göran Pershagen, N. Peter Wiklund, Fredrik Nyberg & Petra J. de Verdier. (2014) The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers. Tumor Biology.
Crossref
Crossref
H. Eugene Liu, Kuan-Jen Bai, Yu-Chen Hsieh, Ming-Chih Yu, Chun-Nin Lee, Jer-Hua Chang, Han-Lin Hsu, Pei-Chih Lu & Hsiang-Yin Chen. (2014) Multiple Analytical Approaches Demonstrate a Complex Relationship of Genetic and Nongenetic Factors with Cisplatin- and Carboplatin-Induced Nephrotoxicity in Lung Cancer Patients. BioMed Research International 2014, pages 1-9.
Crossref
Crossref
Sun Xian, Lang Jilu, Tian Zhennan, Zhou Yang, Hu Yang, Geng Jingshu & Fu Songbin. (2014) BMP-4 Genetic Variants and Protein Expression Are Associated with Platinum-Based Chemotherapy Response and Prognosis in NSCLC. BioMed Research International 2014, pages 1-8.
Crossref
Crossref
Li Liu, Jing Wu, Rong Zhong, Chen Wu, Li Zou, Beifang Yang, Wei Chen, Beibei Zhu, Shengyu Duan, Dianke Yu, Wen Tan, Shaofa Nie, Dongxin Lin & Xiaoping Miao. (2013) Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. Molecular Carcinogenesis 52:12, pages 923-931.
Crossref
Crossref
Tao Zhang, Ningning Rong, Juan Chen, Chengwei Zou, Haiyan Jing, Xiaolong Zhu & Wenlong Zhang. (2013) SIRT1 Expression Is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC. PLoS ONE 8:11, pages e79162.
Crossref
Crossref
Xia Pu, Jack A. Roth, Michelle A.T. Hildebrandt, Yuanqing Ye, Hua Wei, John D. Minna, Scott M. Lippman & Xifeng Wu. (2013) MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients. Cancer Research 73:6, pages 1867-1875.
Crossref
Crossref
Dairong Li, Qi Zhou, Yu Liu, Yanqing Yang & Qiying Li. (2011) DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. Medical Oncology 29:3, pages 1622-1628.
Crossref
Crossref
Crist?bal Aguilar-Gallardo, Emily Cecilia Rutledge, Ana M. Mart?nez-Arroyo, Juan Jos? Hidalgo, Santiago Domingo & Carlos Sim?n. (2012) Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches. Stem Cell Reviews and Reports 8:3, pages 994-1010.
Crossref
Crossref
Elisa Giovannetti, Francesca Toffalorio, Tommaso De Pas & Godefridus J Peters. (2012) Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?. Pharmacogenomics 13:9, pages 1073-1086.
Crossref
Crossref
Ji-Ye Yin, Qiong Huang, Ying-Chun Zhao, Hong-Hao Zhou & Zhao-Qian Liu. (2012) Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients. PLoS ONE 7:6, pages e38150.
Crossref
Crossref
Xiao Zhu, Marie C.M. Lin, Wenguo Fan, Linwei Tian, Jinlong Wang, Samuel S. Ng, Min Wang, Hsiangfu Kung & Dongpei Li. (2012) An Intronic Polymorphism in GRP78 Improves Chemotherapeutic Prediction in Non-small Cell Lung Cancer. Chest 141:6, pages 1466-1472.
Crossref
Crossref
Wenshan He, Sijia Luo, Tao Huang, Jinghua Ren, Xiaoling Wu, Jun Shao & Qingyao Zhu. (2011) The Ku70 −1310C/G promoter polymorphism is associated with breast cancer susceptibility in Chinese Han population. Molecular Biology Reports 39:1, pages 577-583.
Crossref
Crossref
Jingyao Dai, Jian Gu, Charles Lu, Jie Lin, David Stewart, David Chang, Jack A. Roth & Xifeng Wu. (2011) Genetic Variations in the Regulator of G-Protein Signaling Genes Are Associated with Survival in Late-Stage Non-Small Cell Lung Cancer. PLoS ONE 6:6, pages e21120.
Crossref
Crossref
Xifeng Wu, Yuanqing Ye, Rafael Rosell, Christopher I. Amos, David J. Stewart, Michelle A.T. Hildebrandt, Jack A. Roth, John D. Minna, Jian Gu, Jie Lin, Shama C. Buch, Tomoko Nukui, Jose Luis Ramirez Serrano, Miquel Taron, Adrian Cassidy, Charles Lu, Joe Y. Chang, Scott M. Lippman, Waun Ki Hong, Margaret R. Spitz, Marjorie Romkes & Ping Yang. (2011) Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy. JNCI: Journal of the National Cancer Institute 103:10, pages 817-825.
Crossref
Crossref
Dong Liang, Larissa Meyer, David W. Chang, Jie Lin, Xia Pu, Yuanqing Ye, Jian Gu, Xifeng Wu & Karen Lu. (2010) Genetic Variants in MicroRNA Biosynthesis Pathways and Binding Sites Modify Ovarian Cancer Risk, Survival, and Treatment Response. Cancer Research 70:23, pages 9765-9776.
Crossref
Crossref
Nathalie Wauthoz, Philippe Deleuze, Julien Hecq, Isabelle Roland, Sven Saussez, Ivan Adanja, Olivier Debeir, Christine Decaestecker, Véronique Mathieu, Robert Kiss & Karim Amighi. (2010) In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy. European Journal of Pharmaceutical Sciences 39:5, pages 402-411.
Crossref
Crossref